ArticleCancer immunology, immunotherapy : CII2023

Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study.

Airi Fujimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.